Novavax Says U.S. Will Pause Funding for Production of Its Vaccine
WASHINGTON — Novavax, the Maryland firm that won a $1.75 billion federal contract to develop and produce a coronavirus vaccine, said on Thursday that the federal government would not fund further production of its vaccine until the company resolves concerns of federal regulators about its work. The firm’s disclosure came in a quarterly filing with…